<p>Embodied medicinal plant knowledge (EMPK) for treating children’s diseases is a crucial component in understanding the development of local medical systems (LMSs) throughout the human lifespan. However, there are different gaps in knowledge on how the EMPK develops and differentiates throughout people’s lives, as well as the factors involved. The role of human life history, or human ontogeny, can help us solve this investigation problem. Here, in a small mixed-subsistence community (<i>n</i> = 103) in Brazil, we investigate the role of life history in the construction of knowledge about medicinal plants to treat children’s diseases by our species. Our contributions suggest that the EMPK for treating children’s diseases is more appropriate for the reproductive and post-reproductive stages than the pre-reproductive period. Additionally, women have a broader and consistent knowledge of the category of disease investigated than men. Finally, our results show that the number of children and grandchildren increases of EMPK in treating children’s diseases. Taken together, these insights suggest that human life history plays a central role in the construction of EMPK associated with children’s diseases.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

The Role of Human Life History in Structuring Embodied Medicinal Plant Knowledge on Children’s Diseases

  • Jorge Izaquiel Alves de Siqueira,
  • Patrícia Muniz de Medeiros,
  • Ulysses Paulino Albuquerque

摘要

Embodied medicinal plant knowledge (EMPK) for treating children’s diseases is a crucial component in understanding the development of local medical systems (LMSs) throughout the human lifespan. However, there are different gaps in knowledge on how the EMPK develops and differentiates throughout people’s lives, as well as the factors involved. The role of human life history, or human ontogeny, can help us solve this investigation problem. Here, in a small mixed-subsistence community (n = 103) in Brazil, we investigate the role of life history in the construction of knowledge about medicinal plants to treat children’s diseases by our species. Our contributions suggest that the EMPK for treating children’s diseases is more appropriate for the reproductive and post-reproductive stages than the pre-reproductive period. Additionally, women have a broader and consistent knowledge of the category of disease investigated than men. Finally, our results show that the number of children and grandchildren increases of EMPK in treating children’s diseases. Taken together, these insights suggest that human life history plays a central role in the construction of EMPK associated with children’s diseases.